Opportunity Information: Apply for PAR 21 032

The NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32, Clinical Trial Not Allowed), Funding Opportunity Number PAR-21-032, is a National Institutes of Health fellowship program designed to support the mentored research training of highly promising postdoctoral scientists who are pursuing neuroscience-related research aligned with the mission of the National Institute of Neurological Disorders and Stroke (NINDS). As an individual fellowship mechanism, it is centered on the applicant as a developing scientist and is meant to pair strong candidates with outstanding mentors and training environments so the fellow can build the skills, record of productivity, and professional readiness needed for a successful independent research career.

A defining feature of this NINDS F32 is the emphasis on applying early. Candidates can submit an application as early as 12 months before the start of the proposed postdoctoral appointment and up to 12 months after beginning the postdoc. This early eligibility window is intentional: the program is structured to encourage thoughtful, goal-directed planning at the very start of postdoctoral training rather than waiting until later years. Related to that goal, the opportunity explicitly discourages reliance on extensive preliminary data, which helps make it feasible to propose ambitious, bold, or innovative projects even when the candidate is still transitioning into a new lab or research direction. In practice, reviewers expect a compelling rationale, a strong scientific approach, and a well-constructed training plan, rather than a large body of already-completed results.

Another major expectation is rigorous quantitative preparation. Applications are expected to include strong training in quantitative reasoning and the quantitative principles of experimental design and analysis. That typically means the fellowship plan should demonstrate that the candidate will gain concrete skills in areas such as study design, statistics, reproducible workflows, data management, and appropriate analytic methods for the proposed research (for example, computational approaches, modeling, high-dimensional data analysis, or other quantitative techniques relevant to neuroscience). The intent is to ensure fellows not only conduct strong research during the award period, but also develop habits and competencies that improve rigor and transparency throughout their careers.

The fellowship is also designed to promote timely completion of mentored postdoctoral training within a single research environment. NINDS limits support under this program to the first three years of the candidate’s activity in a specific laboratory or research environment. This policy reinforces the program’s early-application philosophy and helps ensure the fellowship is used for structured, mentored development at the beginning of the postdoc, rather than as an extension of later-stage training.

As indicated by the parenthetical note in the title, clinical trials are not allowed under this opportunity. Applicants must propose research and training activities that fit within NIH’s definition of not involving a clinical trial, meaning the project should not be designed to prospectively assign human participants to an intervention to evaluate its effects on health-related biomedical or behavioral outcomes. This does not necessarily prevent all human-focused research, but it does restrict the application from including a clinical trial component under NIH rules.

From an administrative standpoint, this is a discretionary grant opportunity in the health funding category (CFDA 93.853) offered by the National Institutes of Health. The opportunity is listed as a reissue of PAR-20-021, reflecting continuity in purpose while operating under the PAR-21-032 announcement. The original closing date provided in the source data is 2025-01-07.

Eligibility for applicant organizations is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), for-profit organizations (other than small businesses), and small businesses, among others. The opportunity also highlights a range of other eligible applicant types and institutional categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, and non-domestic (non-U.S.) entities (foreign organizations). This breadth signals an intent to enable participation across many institutional settings and training environments, including international organizations where permitted under the announcement.

Overall, PAR-21-032 is best understood as an early-stage postdoctoral fellowship that prioritizes the candidate’s potential, the quality of mentorship and training environment, careful planning, and strong quantitative rigor, while giving applicants room to propose high-impact ideas without being penalized for not yet having extensive preliminary results. The program’s three-year-in-lab support limit and early eligibility window are designed to push applicants to seek fellowship support at the start of their postdoctoral period and to complete mentored training efficiently within one primary research setting.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853.
  • This funding opportunity was created on 2020-10-15.
  • Applicants must submit their applications by 2025-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 032

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Training Services

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)

Previous opportunity: Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 032

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 032) also looked into and applied for these:

Funding Opportunity
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) Apply for RFA AI 20 076

Funding Number: RFA AI 20 076
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) Apply for PAR 21 037

Funding Number: PAR 21 037
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for PAR 21 055

Funding Number: PAR 21 055
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for PAR 21 054

Funding Number: PAR 21 054
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Improving Health Status and Human Capital in Senegal Apply for 72068521APS00001

Funding Number: 72068521APS00001
Agency: Senegal USAID-Dakar
Category: Health
Funding Amount: $88,000,000
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed) Apply for PAR 20 311

Funding Number: PAR 20 311
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 21 040

Funding Number: PAR 21 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Treatments for Lewy Body Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 21 008

Funding Number: RFA NS 21 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Regional Technology Transfer Accelerator Hubs for IDeA States (STTR) (UT2 - Clinical Trial Not Allowed) Apply for RFA GM 21 001

Funding Number: RFA GM 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection (R01 Clinical Trial Optional) Apply for RFA MD 21 001

Funding Number: RFA MD 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 007

Funding Number: RFA RM 21 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) Apply for RFA MD 21 002

Funding Number: RFA MD 21 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) Apply for PAR 21 077

Funding Number: PAR 21 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 21 036

Funding Number: PAR 21 036
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) Apply for PAR 21 045

Funding Number: PAR 21 045
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R43/R44 Clinical Trial Optional) Apply for RFA MH 21 112

Funding Number: RFA MH 21 112
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 21 072

Funding Number: PAR 21 072
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 21 053

Funding Number: PAR 21 053
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional) Apply for RFA MH 21 111

Funding Number: RFA MH 21 111
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) Apply for RFA MH 21 110

Funding Number: RFA MH 21 110
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 032", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: